Skip to main
AXSM

Axsome Therapeutics (AXSM) Market Capitalization Overview

Market Cap: $8.45B as of Jan 8, 2026

$8.45B
$1.01B (13.55%)past month
As of Jan 8, 2026, Axsome Therapeutics (AXSM) has a market capitalization of $8.45B. Over the past 30 days, its market cap has increased by 19.9%, while in the last 12 months, it has decreased by -8.26%.

Market capitalization represents the total value of Axsome Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Axsome Therapeutics (AXSM) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Axsome Therapeutics (AXSM) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Axsome Therapeutics (AXSM) Market Cap History

DateMarket CapChange
Dec 1, 2025$7.52B+10.91%
Nov 3, 2025$6.78B+14.49%
Oct 1, 2025$5.92B-3.97%
Sep 2, 2025$6.17B+21.47%
Aug 1, 2025$5.08B+0.05%
Jul 1, 2025$5.07B-4.36%
Jun 2, 2025$5.31B-3.15%
May 1, 2025$5.48B+0.51%
Apr 1, 2025$5.45B-12.17%
Mar 3, 2025$6.21B+19.10%
Feb 3, 2025$5.21B+23.03%
Jan 2, 2025$4.24B-11.87%

Axsome Therapeutics (AXSM) End of Year Market Cap History

DateMarket CapChange
2026$8.45B-8.26%
2025$9.21B+124.55%
2024$4.11B+8.87%
2023$3.77B+12.44%
2022$3.35B+135.22%
2021$1.43B

FAQs About Axsome Therapeutics (AXSM) Market Cap

As of Jan 8, 2026, the market capitalization of Axsome Therapeutics (AXSM) is $8.45B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Axsome Therapeutics’s market capitalization has increased by 13.55%, changing from $7.44B to $8.45B as of Jan 8, 2026.

In the last 3 months, Axsome Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Axsome Therapeutics’s market capitalization increased from $4.11B in January to $9.21B in December, reflecting a 124.55% change.

In the past five years, Axsome Therapeutics (AXSM) has had a compound annual growth rate (CAGR) of 45.25% in market capitalization. This means its market cap has grown at an average rate of 45.25% per year.

Axsome Therapeutics (AXSM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.